Charles River Laboratories International Inc (NYSE:CRL)
| 316.72 BATS BZX Real-Time Price As of 1:12pm ET |  -13.37 / -4.05%Today’s Change | 249.48 Today|||52-Week Range 460.21 | -15.94% Year-to-Date |
Latest CRL News | Press Releases
| Strs Ohio Buys iShares MSCI EAFE ETF, ZoomInfo Technologies Inc, Mastercard Inc, Sells Oracle ... Jan 24 / GuruFocus News - Paid Partner Content | 3 Reasons Why Charles River (CRL) Is a Great Growth Stock Jan 19 / Zacks.com - Paid Partner Content |
| New Potomac Partners, LLC Buys Simon Property Group Inc, Invesco BulletShares 2027 Corporate ... Jan 21 / GuruFocus News - Paid Partner Content | Andreas Halvorsen Reinforces Guardant Health Bet Jan 19 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 330.09 |
| Today’s open | 320.75 |
| Day’s range | 314.97 - 321.72 |
| Volume | 215,292 |
| Average volume (3 months) | 400,832 |
| Market cap | $16.4B |
Data as of 1:12pm ET, 01/25/2022
Growth & Valuation
| Earnings growth (last year) | +42.16% |
| Earnings growth (this year) | +26.26% |
| Earnings growth (next 5 years) | +16.00% |
| Revenue growth (last year) | +11.55% |
| P/E ratio | 40.8 |
| Price/Sales | 4.36 |
| Price/Book | 7.64 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ICLRICON PLC | -6.10 | -2.38% |
| ---- | ||
| SYNHSyneos Health Inc | -1.95 | -2.22% |
| MEDPMedpace Holdings Inc | -4.53 | -2.64% |
Data as of 1:16pm ET, 01/25/2022
Financials
| Next reporting date | February 16, 2022 |
| EPS forecast (this quarter) | $2.43 |
| Annual revenue (last year) | $2.9B |
| Annual profit (last year) | $364.3M |
| Net profit margin | 12.46% |
Profile
Sector Commercial Services |
Industry Miscellaneous Commercial Services |
No executives to display |
Corporate headquarters Wilmington, Massachusetts |
Forecasts
